Good morning DD2 and thanks for the quick post tod
Post# of 72440
It's time to drown the shorts.
"Cellceutix finds it encouraging that 6 of 10 tumors in the group treated with the combination of Kevetrin and 30 mg/kg docetaxel have been reduced to the point that they are not measurable."
A blind man could read this. This should be a positive week and garner much price support.
GO CTIX